PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Early Engagement with Payers: 5 Ways to Succeed

Pharm Exec’s Industry Audit 2017

How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity

Advertisement
Strategy
Challenges for Early Entrants in the NASH Market
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the non-alcoholic steatohepatitis market
/Read more/
Advertisement
Looking for physician respondents for your surveys?
With advanced targeting, unmatched recruitment, and the industry’s leading network of active physicians, Medscape Market Research gets you the respondents and results you need. Learn about the Medscape difference today.
Learn more
Strategy
NASH: Pointers for Pharma from the Patient Perspective
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment
/Read more/
Advertisement
Partnerships in Clinical Trials Europe | 28-29 November 2017 | RAI, Amsterdam
PCT Europe brings you the latest information from across the clinical trials industry with direct access to leading innovators. Join 1000+ industry peers for 8 tracks covering:
  • Partnerships and Collaboration
  • Investigator and industry: How can they work together?
  • Mobile eHealth
  • Governance, Oversight and Quality
  • Partnership Management
  • Patients as Partners
  • Disruptive Innovation, Technology and Big Data
  • Small to Mid-Size Pharma and Biotech
Learn more
Oncology
The Rising Tide of Next Generation Cancer Treatments
Jackie Ilacqua & Valerie Wriede trace the evolution of cancer treatment and drill down into the latest developments currently redefining the landscape, together with those on the horizon
/Read more/
Advertisement
Launching into Value: Pharma’s Quest to Align Drug Prices with Outcomes
Live Webcast: Wednesday, October 11 at 11:00am EDT
Register now
Regulatory
Will “Interchangeability” Boost Biosimilar Prescribing?
While biopharma companies have pressed hard for clarity on the data required to gain market approval of biosimilars that can be filled by a pharmacist without prescriber pre-approval, the progress towards "interchangeability" has been slow. Jill Wechsler reports
/Read more/
Advertisement
How Can Scientific Dissemination Data Help Medical Affairs Adopt a more Strategic Role?
On Demand
Learn more
Advertisement
Driving compounds forward
Capsugel’s unique combination of drug and process design capabilities – coupled with premier depth in bioavailability enhancement and targeted delivery technologies – enable us to deliver the right solution for challenging compounds. We bring design to the CDMO space.
Learn more at www.capsugel.com.
Calendar
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ October 26–27: MedComm /
San Francisco, CA
/ 14 November: EU GDPR Bootcamp Life Sciences /
London, UK
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Commercial Data Insights /
Philadelphia, PA
/ December 4–5: Connected Devices in Healthcare /
San Diego, CA
/ February 7–8, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
Advertisement
Value-Based Strategies for Reimbursement and Formulary Success
ExL’s first annual Value-Based Strategies for Reimbursement and Formulary Success Event is taking place on November 7-8 in Bethesda MD. This event will pioneer the conversation of the transition from price-centric to value-based formularies. Life science and healthcare insurance executives will provide attendees with education in proving value, instead of managing pricing of drugs coming onto the market.
Learn more
Advertisement
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
Live Webcast: Wednesday, October 18 at 11:00am EDT
Register now
Industry update
//BioMarin Pharmaceutical (San Rafael, CA) appointed former Baxalta Chief Financial Officer and Chief Operations Officer, Robert J. Hombach, to its Board of Directors. //Dr. Gloria Matthews joined MiMedx Group (Marietta, GA) as Senior Vice President, Research and Development. //Impel NeuroPharma (Seattle, WA) announced the appointment of veteran biotech executive Jon Congleton as the company’s new President and CEO. //Acerus Pharmaceuticals Corporation (Toronto, Canada) announced that Mr. Tom Rossi, President and Chief Executive Officer, departed from the company on October 2. Luc Mainville was appointed interim CEO. //Lizanne Muller joined Envigo (Princeton, NJ) as President EMEA Operations. //
Advertisement
RIM Best Practices: Unifying Data, Content & Regulatory Processes
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com